soul trial oral semaglutide cardiovascular outcomes results In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress soul trial oral semaglutide cardiovascular

Alternative medications like orlistat and phentermine work differently and may have varied efficacy and side effect profiles

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

Helps control appetite and cravings

Acknowledgments We are grateful for the academic support of our universities: Universidad Veracruzana and Universidad Nacional Autnoma de Mxico, as they simplified access to the principal scientific databases through the purchase of CCDC and SciFinder academic permissions

Brand-name medications have large-scale clinical trials supporting their safety and effectiveness